| Code | Description | Claims | Beneficiaries | Total Paid |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
345 |
322 |
$15K |
| 84443 |
Thyroid stimulating hormone (TSH) |
749 |
703 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,464 |
1,339 |
$12K |
| 80061 |
Lipid panel |
651 |
626 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
289 |
273 |
$9K |
| 80053 |
Comprehensive metabolic panel |
604 |
569 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
506 |
242 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
2,082 |
1,827 |
$6K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
196 |
184 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
447 |
428 |
$5K |
| 86738 |
|
265 |
250 |
$5K |
| 82607 |
|
233 |
219 |
$4K |
| 81000 |
|
1,011 |
923 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
52 |
50 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
52 |
50 |
$2K |
| 80074 |
|
44 |
43 |
$2K |
| 82274 |
|
133 |
131 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
241 |
222 |
$2K |
| 84439 |
|
194 |
182 |
$2K |
| 82043 |
|
250 |
239 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
133 |
127 |
$1K |
| 82570 |
|
186 |
170 |
$1K |
| 86592 |
|
176 |
168 |
$782.31 |
| 86803 |
|
29 |
28 |
$449.27 |
| 86708 |
|
31 |
31 |
$404.45 |
| 85651 |
|
96 |
94 |
$360.20 |
| 86706 |
|
31 |
31 |
$352.02 |
| 84153 |
|
12 |
12 |
$230.60 |
| 82947 |
|
34 |
30 |
$140.37 |
| 84436 |
|
15 |
15 |
$110.98 |
| 84479 |
|
13 |
13 |
$91.07 |
| 85730 |
|
12 |
12 |
$70.07 |
| 86140 |
|
14 |
13 |
$65.84 |
| 85610 |
|
12 |
12 |
$46.65 |